Grow Pharma and Integro Clinics launch new UK patient access scheme

Cannabis News World

Aug 2

Grow Pharma and Integro Clinics launch new UK patient access scheme
Cannabis Health News

A new scheme, The Grow Access Project, is offering 500 free initial consultations to eligible patients to help reduce barriers to access in the UK. One of the UK's leading distributors of cannabis-based medicines, Grow Pharma, has announced the launch of The Grow Access Project in collaboration with Integro Medical Clinics. The scheme aims to further reduce the barrier to access to prescribed cannabis medicines for patients on low-income benefit, as well as making it more accessible to veterans of UK armed forces. Patients on the scheme will be able to access Grow Pharma's own-brand flower products, which launched in 2022, for a reduced price, as well as being offered cheaper consultation fees. Medical cannabis was legalised in the UK in 2018, but only a handful of prescriptions have been issued on the NHS. This means that patients are forced to access cannabis medicines through the private sector, the cost of which can be a significant barrier. The Grow range, launched in May, includes five flower medicines cultivated in North-Macedonia by EU-GMP licensed producer PHCANN, and is the lowest priced range of flowers available through Grow-IPS Pharma alongside the Aurora, Tilray and Spectrum ranges.It is being launched at £6.50 per gram for products containing less than 18 per cent THC, £7.50 per gram for those containing 18 – 22 per cent THC and £8.50 for any higher THC content flowers. Patients eligible for the Grow Access Project will be able to access the full range for £6.50 per gram. In addition, Integro Medical Clinics are offering the first 500 eligible new patients their first consultation for free with a new reduced fee system following. Pierre Van Weperen, Grow Pharma CEO, commented: "We're very excited to be launching the Grow Access Project. As Grow Pharma we prioritise quality, consistency and reliability…